In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.

The obesity drug helped people trim about two inches more off their waists than Wegovy in the first head-to-head study of the ...

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...

And nearly 32% of individuals taking Zepbound lost at roughly a quarter of their body weight, compared to about 16% of those ...

Dr. Naderi Introducing Zepbound The expert team at The Naderi Center has developed a comprehensive approach that addresses the unique needs of men. Recognizing that male facial anatomy ...

Eli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nordisk A/S’s ...

A new study has found that people taking Eli Lilly's obesity drug Zepbound lost almost 50% more weight than those using Novo ...

Zepbound is newer medication than Wegovy ... Researchers say that result was driven by men, who lost about 6% less weight than women. About 35% of participants in this study were men, while ...

Dr. Naderi Introducing Zepbound The expert team at The Naderi Center has developed a comprehensive approach that addresses the unique needs of men. Recognizing that male facial anatomy, aesthetic ...

In today’s Health Alert, two popular weight loss drugs went head-to-head in a clinical trial – and one came out on top.

Eli Lilly’s obesity drug Zepbound led to nearly 50 percent more weight loss than Novo Nordisk’s Wegovy in the first direct ...